Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Paus

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Journal of Neural Transmission (Vienna, Austria : 1996)|March 23, 2025
Real-world experience with continuous subcutaneous foslevodopa/foscarbidopa infusion: insights and recommendationsThomas Koeglsperger, Emir Berberovic, Christian Dresel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 16, 2004
Association study of dopamine D2, D3, D4 receptor and serotonin transporter gene polymorphisms with sleep attacks in Parkinson's diseaseSebastian Paus, Gert Seeger, Hans M Brecht, et al.
Neuroreport|August 2, 2002
Transcriptional profiling in human epilepsy: expression array and single cell real-time qRT-PCR analysis reveal distinct cellular gene regulationAlbert J Becker, Jian Chen, Sebastian Paus, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 5, 2008
The DRD2 TaqIA polymorphism and demand of dopaminergic medication in Parkinson's diseaseSebastian Paus, Anne Grünewald, Christine Klein, et al.
Psychiatric Genetics|November 27, 2004
Systematic screening for mutations in the human N-methyl-D-aspartate receptor 1 gene in schizophrenic patients from the German populationSebastian Paus, Marcella Rietschel, Thomas G Schulze, et al.
Neurological Research and Practice|January 15, 2025
Increase of nitrous oxide-induced neurological disorders - a German multicenter experienceJulius Nicolai Meißner, Janina Neuneier, Iason Bartzokis, et al.
Neuroscience Letters|March 31, 2004
Lack of association between the interleukin-1 alpha (-889) polymorphism and early-onset Parkinson's diseaseJens Carsten Möller, Candan Depboylu, Heike Kölsch, et al.
Movement Disorders Clinical Practice|May 29, 2025
Long-Term Safety and Efficacy of Repeat Treatments with DaxibotulinumtoxinA in Cervical Dystonia: Results from the ASPEN-Open-Label StudyPeter McAllister, Atul T Patel, Marta Banach, et al.
Fortschritte Der Neurologie-Psychiatrie|April 22, 2022
[Treatment of Sialorrhea with Botulinum Neurotoxin Type A - Consensus Practice Recommendations for Children and Adults]Wolfgang H Jost, Tobias Bäumer, Andrea Bevot, et al.
Fortschritte Der Neurologie-Psychiatrie|June 15, 2022
[Correction: Treatment of Sialorrhea with Botulinum Neurotoxin Type A - Consensus Practice Recommendations for Children and Adults]Wolfgang H Jost, Tobias Bäumer, Andrea Bevot, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Journal of Neural Transmission (Vienna, Austria : 1996)|March 23, 2025
Real-world experience with continuous subcutaneous foslevodopa/foscarbidopa infusion: insights and recommendationsThomas Koeglsperger, Emir Berberovic, Christian Dresel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 16, 2004
Association study of dopamine D2, D3, D4 receptor and serotonin transporter gene polymorphisms with sleep attacks in Parkinson's diseaseSebastian Paus, Gert Seeger, Hans M Brecht, et al.
Neuroreport|August 2, 2002
Transcriptional profiling in human epilepsy: expression array and single cell real-time qRT-PCR analysis reveal distinct cellular gene regulationAlbert J Becker, Jian Chen, Sebastian Paus, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 5, 2008
The DRD2 TaqIA polymorphism and demand of dopaminergic medication in Parkinson's diseaseSebastian Paus, Anne Grünewald, Christine Klein, et al.
Psychiatric Genetics|November 27, 2004
Systematic screening for mutations in the human N-methyl-D-aspartate receptor 1 gene in schizophrenic patients from the German populationSebastian Paus, Marcella Rietschel, Thomas G Schulze, et al.
Neurological Research and Practice|January 15, 2025
Increase of nitrous oxide-induced neurological disorders - a German multicenter experienceJulius Nicolai Meißner, Janina Neuneier, Iason Bartzokis, et al.
Neuroscience Letters|March 31, 2004
Lack of association between the interleukin-1 alpha (-889) polymorphism and early-onset Parkinson's diseaseJens Carsten Möller, Candan Depboylu, Heike Kölsch, et al.
Movement Disorders Clinical Practice|May 29, 2025
Long-Term Safety and Efficacy of Repeat Treatments with DaxibotulinumtoxinA in Cervical Dystonia: Results from the ASPEN-Open-Label StudyPeter McAllister, Atul T Patel, Marta Banach, et al.
Fortschritte Der Neurologie-Psychiatrie|April 22, 2022
[Treatment of Sialorrhea with Botulinum Neurotoxin Type A - Consensus Practice Recommendations for Children and Adults]Wolfgang H Jost, Tobias Bäumer, Andrea Bevot, et al.
Fortschritte Der Neurologie-Psychiatrie|June 15, 2022
[Correction: Treatment of Sialorrhea with Botulinum Neurotoxin Type A - Consensus Practice Recommendations for Children and Adults]Wolfgang H Jost, Tobias Bäumer, Andrea Bevot, et al.
Pageof 5